1. Home
  2. BNBX vs SXTP Comparison

BNBX vs SXTP Comparison

Compare BNBX & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BNBX

Applied DNA Sciences Inc.

N/A

Current Price

$0.52

Market Cap

3.6M

ML Signal

N/A

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$1.63

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNBX
SXTP
Founded
1983
2010
Country
United States
United States
Employees
26
3
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
2.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNBX
SXTP
Price
$0.52
$1.63
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.10
AVG Volume (30 Days)
375.2K
195.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$253.12
$33.92
Revenue Next Year
N/A
$51.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.34
52 Week High
$6.17
$8.62

Technical Indicators

Market Signals
Indicator
BNBX
SXTP
Relative Strength Index (RSI) 30.56 41.99
Support Level N/A $1.27
Resistance Level $0.82 $1.84
Average True Range (ATR) 0.08 0.19
MACD -0.00 0.02
Stochastic Oscillator 12.23 3.75

Price Performance

Historical Comparison
BNBX
SXTP

About BNBX Applied DNA Sciences Inc.

BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Share on Social Networks: